Cornerstone Advisory’s Voyager Therapeutics VYGR Stock Holding History

Cornerstone Advisory’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13	Closed	–	–	782
2021 Q4	$0	Buy	+13	New	+$44	﹤0.01%	848

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cornerstone Advisory's VYGR Position: Q1 2022 in Review

Cornerstone Advisory sold out of Voyager Therapeutics (VYGR) in Q1 2022, closing a stake of 13 shares.

Cornerstone Advisory first reported a position in VYGR in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 70 funds tracked by Wall St. Rank hold VYGR as of Q1 2022.

Cornerstone Advisory reported no remaining Voyager Therapeutics position as of Q1 2022 after selling out during the quarter.
Cornerstone Advisory sold 13 Voyager Therapeutics shares in Q1 2022.
Cornerstone Advisory first reported a position in Voyager Therapeutics in Q4 2021 and held it in 1 quarter.
Cornerstone Advisory's Voyager Therapeutics position peaked at $0 in Q4 2021.
70 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2022.

Based on Cornerstone Advisory's 13F filing for Q1 2022, filed 20 May 2022.